Loading viewer...
investor_presentation
Format: PDF investor_presentation
Chimerix's corporate presentation outlines investment highlights and forward-looking statements regarding their clinical studies and market potential for ONC201 and ONC206.
investor_presentation
16 Pages
Samsung Foundry
investor_presentation
Oncolytics